203
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support

, , , , , , , , & show all
Pages 1482-1486 | Received 04 Aug 2015, Accepted 20 Sep 2015, Published online: 16 Nov 2015
 

Acknowledgements

We thank Anna-Lena Schachtner and Rudina Marx for her skilled and dedicated technical assistance.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.3109/10428194.2015.1099648

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.